Key Slides on Individualizing ART Management Based on Treatment Safety and Tolerability

Review data and guideline recommendations informing ART management for specific patient populations to improve tolerability and minimize adverse events and potential drug-drug interactions
Kristine Erlandson, MD
Rajesh T. Gandhi, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 580 KB
Released: April 24, 2020


Provided by USF Health

Contact Clinical Care Options

For customer support please email:

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Janssen Therapeutics, Division of Janssen Products, LP

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings